Juxtapid Drug Interactions: 233 Major, 680 Moderate
Juxtapid (Lomitapide Mesylate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Juxtapid. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Lomitapide.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Abiraterone is combined with Lomitapide.
Level 2 evidence
Acalabrutinib
The metabolism of Lomitapide can be decreased when combined with Acalabrutinib.
Level 1 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Lomitapide.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Lomitapide.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Lomitapide.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Aceclofenac is combined with Lomitapide.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Lomitapide.
Level 1 evidence
Acetaminophen
The metabolism of Lomitapide can be decreased when combined with Acetaminophen.
Level 1 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Lomitapide.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of liver damage can be increased when Acetylsalicylic acid is combined with Lomitapide.
Level 2 evidence
Acitretin
The risk or severity of liver damage can be increased when Acitretin is combined with Lomitapide.
Level 2 evidence
Enter your NPI to unlock 22 major interactions for Juxtapid
Juxtapid (Lomitapide Mesylate) has 1015 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Juxtapid (Lomitapide Mesylate) has 233 major, 680 moderate, and 102 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Juxtapid. Always confirm against the full prescribing information.